🇺🇸 FDA

Drug profile · INN

buprenorphine

BUPRENORPHINE NEURAXPHARM

approved N07BC51
US status
approved
Patents linked
8
News articles
0

Quick answer

buprenorphine (BUPRENORPHINE NEURAXPHARM) is an FDA-listed pharmaceutical active ingredient. Associated with Indivior Europe Limited. Route of administration: subcutaneous. Current US regulatory status: approved.

Key facts

INN buprenorphine
Brand BUPRENORPHINE NEURAXPHARM
Route SUBCUTANEOUS
Formulation FILM, EXTENDED RELEASE
ATC code N07BC51
Originator Indivior Europe Limited

Related patents

Search patents →

  1. US 11839611

    Buprenorphine dosing regimens

    Expires Mon Dec 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 11000520

    Buprenorphine dosing regimens

    Expires Mon May 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 10592168

    Injectable flowable composition comprising buprenorphine

    Expires Mon Mar 12 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 10558394

    Injectable flowable composition comprising buprenorphine

    Expires Mon Feb 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 10517864

    Sustained-release buprenorphine solutions

    Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 10198218

    Injectable flowable composition comprising buprenorphine

    Expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 10172849

    Compositions comprising buprenorphine

    Expires Mon Jan 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 10022367

    Sustained-release buprenorphine solutions

    Expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is buprenorphine?

buprenorphine (BUPRENORPHINE NEURAXPHARM) is an FDA-listed pharmaceutical active ingredient. Associated with Indivior Europe Limited. Route of administration: subcutaneous. Current US regulatory status: approved.

What is the brand name for buprenorphine?

BUPRENORPHINE NEURAXPHARM is a marketed brand name for buprenorphine. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of buprenorphine?

buprenorphine has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.